Trial Profile
A study evaluating effect of vessel size on clinical outcomes after stenting with Umirolimus Eluting Stent (BiomatrixTM)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2018
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms BEAUTY
- 27 Feb 2016 New trial record